📢Today is #InternationalSelfCareDay. Self-care is a priority for NET patients.
👉Share your experience in a NET patient group: find one across the globe among INCA members: https://t.co/ZZpiLkdUNl
#LetsTalkAboutNETs
📢Today is International Yoga Day. Yoga and meditation can alleviate anxiety, stress, fatigue – often experienced along the neuroendocrine cancer patient journey.
👉Reach out to your patient group anywhere in the world: https://t.co/THMTwToVxl
#LetsTalkAboutNETs
Neuroendocrine Cancer patient, Jane Aylott, from @RoyalFreeNHS joined us in Parliament as MP's pledged to support first ever ideal NHS patient pathway for this cancer - now the 10th most prevalent in England. @SteveBarclay we need your help to take this forward now #NCCarepathway
Today in Parliament - together with @HealthPolicyPtp - we were delighted to have so many MP's from all parties, pledge their support for the implementation of an NHS patient care pathway for Neuroendocrine Cancer. Time for action @SteveBarclay@APPGC@NHSEnglandLDN#NCCarepathway
Now 10th most prevalent cancer in England, Neuroendocrine Cancer still does not have a well defined NHS pathway.Actress Olivia Williams discusses cost to tax payers when cancer spreads unchecked https://t.co/nUMrwZ5tFT @NHSuk@APPGC@SteveBarclay @StevenHMcIntosh @mancunianmedic
Our Dr. Peter Pisters shares the latest innovations and breakthroughs in cancer diagnosis and treatment at MD Anderson, including the evolution of immunotherapy and development of cell therapy. https://t.co/L7SZa4aB7j @ppisters@CNBC#EndCancer
👉MEN 2A is a rare hereditary condition. It is diagnosed clinically by the occurrence of two or more specific endocrine tumors (MTC, pheo, parathyroid adenoma).
✅Download our new #NETINfo on MEN2A in 10 languages: https://t.co/Pj86quD8Th #EndoTwitter#MedTwitter#PathTwitter
As part of our Kick Tobacco and Vaping Week,
the soccer teams from @AldineISD High School got a visit from @HoustonDynamo player Tate Schmitt and @HoustonDash player Marisa Viggiano. They are proud to be tobacco- and vape-free. #EndCancer
Thank you to all who attended our Netchatter amd especially to @NaglaAKarimMD for such an interesting and informative talk.
This is now available on our YouTube channel to watch. Please remember to like and subscribe to help spread the word of #NET
https://t.co/HHMOKr03bk
We're grateful to our doctors today and every day for their dedication to our patients and their families, advancing research and furthering our mission to #EndCancer. #DoctorsDay
#SteveJobs – the most famous #NeuroendocrineCancer Ambassador we NEVER had - Read more on Ronny Allan - Living with Neuroendocrine Cancer https://t.co/uea9B0qjS4
.@GABOUALFA highlights work in @NEJM by Dr. Lipika Goyal @MGHCancerCenter as an exemplar of biliary tract cancers as the GI malignancy par excellence for next-generation sequencing and therapeutic targeting thereof @curecc @CMECedarsSinai @PamelaKunzMD
https://t.co/qp6Ld5lIUy
Still mind-blowing to realize that, for a select set of rectal cancer patients (locally advanced MSI-H), they may be able to avoid the rigors of total neoadjuvant therapy and instead receive immunotherapy definitively!
@AndreaCercek@MSKCancerCenter
https://t.co/QZBppf0TQN